Tumor-derived TGF-ß and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor.

Bibliographic Information

Published
2014-09-01
Resource Type
journal article

Journal

Details 詳細情報について

Report a problem

Back to top